After 9/11, as our defenses against international and bioterrorism hardened, our
defenses against infectious diseases shrank. By the time a deadly virus arrived
on our shores last year, nearly two-…
In today’s pharmaceutical universe, a simple “safe and effective” determination
by the Food and Drug Administration to approve a drug can be manipulated to sell
products of questionable value. And …
As some states adopt covid vaccine requirements, not everyone agrees mandates
for children are the way forward. Taking a page from history: We have two paths
to putting the pandemic behind us: a qu…
It is a perilous time to throw low- and middle-income Americans off the
insurance cliff: A new omicron subvariant is spreading, and a program that
provided coronavirus testing and covid-19 treatmen…
Drug copayment assistance is a form of profitable charity — and, yes, that’s an
oxymoron. Amid skyrocketing drug prices, it’s understandable that patients
desperately need help affording medi…
One million Americans have died from covid-19 — far more per capita than in any
other developed country. A new variant is doubling case rates in some states,
and more than 300 people are dying a da…
The federal government is stepping in to assist student loan borrowers. But
little public attention has been focused on what is — statistically, at least —
a bigger, broader debt crisis in our coun…
